Products for Research Use Only

Terazosin hydrochloride

CAT: 1410-M15384-01Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:1410-M15384-01Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Terazosin is a selective alpha1-antagonist used for treatment of symptoms of benign prostatic hyperplasia (BPH) .
CAS Number
63074-08-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
423.89
Molecular Formula
C19H26ClN5O4
Notes
Research use only, not for human use.
Receptor
Α-adrenergic receptor

Chemical Information

Terazosin Hydrochloride Anhydrous

See also: Terazosin (has active moiety); Terazosin Hydrochloride (annotation moved to).

CAS Number63074-08-8
PubChem CID44383
IUPAC Name[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone;hydrochloride
Molecular FormulaC19H26ClN5O4
Molecular Weight423.9
Topological Polar Surface Area103
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count8
Rotatable Bond Count4
Heavy Atom Count29
Formal Charge0
Complexity544
SMILES
COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC.Cl
InChI
InChI=1S/C19H25N5O4.ClH/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22);1H
InChIKey
IWSWDOUXSCRCKW-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of Terazosin Hydrochloride Anhydrous
CAS: 63074-08-8
CID: 44383
Formula: C19H26ClN5O4
MW: 423.9
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight423.9
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count8
Rotatable Bond Count4
Exact Mass423.1673320
Monoisotopic Mass423.1673320
Topological Polar Surface Area103 Ų
Heavy Atom Count29
Formal Charge0
Complexity544
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count2
Compound Is CanonicalizedYes